IRADIMED CORPORATION Debt Securities, Trading, Unrealized Loss
IRADIMED CORPORATION (IRMD) reported Debt Securities, Trading, Unrealized Loss of $1.35 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtSecuritiesTradingUnrealizedLoss · last filed 2020-03-06
- IRADIMED CORPORATION debt securities, trading, unrealized loss for the quarter ending 2019-06-30 was -$13.02K.
- IRADIMED CORPORATION debt securities, trading, unrealized loss for the quarter ending 2019-03-31 was $14.37K.
- IRADIMED CORPORATION debt securities, trading, unrealized loss for the quarter ending 2018-12-31 was -$42.25K.
- IRADIMED CORPORATION debt securities, trading, unrealized loss for the quarter ending 2018-09-30 was -$30.65K.
- IRADIMED CORPORATION debt securities, trading, unrealized loss for fiscal 2018 was $58.31K, a 29.05% decline from fiscal 2017.
- IRADIMED CORPORATION debt securities, trading, unrealized loss for fiscal 2017 was $82.19K.
| Period end | Debt Securities, Trading, Unrealized Loss 3 month | Debt Securities, Trading, Unrealized Loss 6 month | Debt Securities, Trading, Unrealized Loss 9 month | Debt Securities, Trading, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2019-06-30 | -$13.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.35K 10-Q · filed 2019-08-07 | -$40.90K derived: sum of 3 quarters · filed 2020-03-06 | -$71.56K derived: sum of 4 quarters · filed 2020-03-06 |
| 2019-03-31 | $14.37K 10-Q · filed 2019-05-08 | -$27.88K derived: sum of 2 quarters · filed 2020-03-06 | -$58.54K derived: sum of 3 quarters · filed 2020-03-06 | |
| 2018-12-31 | -$42.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | -$72.90K derived: sum of 2 quarters · filed 2020-03-06 | $58.31K 10-K · filed 2020-03-06 | |
| 2018-09-30 | -$30.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $100.56K 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $131.21K 10-Q · filed 2018-08-08 | |||
| 2017-12-31 | $82.19K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |